An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides

BACKGROUND: Receptors specific for the sugar N-acetylgalactosamine (GalNAc) include the human type II, C-type lectin receptor macrophage galactose-type lectin/C-type lectin receptor family member 10A (MGL/CLEC10A/CD301) that is expressed prominently by human peripheral immature dendritic cells, dend...

Descripción completa

Detalles Bibliográficos
Autores principales: Eggink, Laura L., Roby, Katherine F., Cote, Robert, Kenneth Hoober, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905120/
https://www.ncbi.nlm.nih.gov/pubmed/29665849
http://dx.doi.org/10.1186/s40425-018-0339-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905120/
https://www.ncbi.nlm.nih.gov/pubmed/29665849
http://dx.doi.org/10.1186/s40425-018-0339-5

Ejemplares similares